dDYRK2 and Minibrain interact with the chromatin remodelling factors SNR1 and TRX

Por Kinstrie, Ross, Lochhead, Pamela A., Sibbet, Gary, Morrice, Nick, Cleghon, Vaughn
Publicado em 2006

dDYRK2: a novel dual-specificity tyrosine-phosphorylation-regulated kinase in Drosophila.

Por Lochhead, Pamela A, Sibbet, Gary, Kinstrie, Ross, Cleghon, Tava, Rylatt, Margie, Morrison, Deborah K, Cleghon, Vaughn
Publicado em 2003

DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome

Por Najas, Sònia, Arranz, Juan, Lochhead, Pamela A., Ashford, Anne L., Oxley, David, Delabar, Jean M., Cook, Simon J., Barallobre, María José, Arbonés, Maria L.
Publicado no EBioMedicine (2015)

Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation

Por Lochhead, Pamela A., Clark, Jonathan, Wang, Lan-Zhen, Gilmour, Lesley, Squires, Matthew, Gilley, Rebecca, Foxton, Caroline, Newell, David R., Wedge, Stephen R., Cook, Simon J.
Publicado no Cell Cycle (2016)

Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome

Por Ashford, Anne L., Dunkley, Tom P. J., Cockerill, Mark, Rowlinson, Rachel A., Baak, Lisa M., Gallo, Raffaella, Balmanno, Kathryn, Goodwin, Louise M., Ward, Richard A., Lochhead, Pamela A., Guichard, Sylvie, Hudson, Kevin, Cook, Simon J.
Publicado no Cell Mol Life Sci (2015)